Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 150 participants.
Also called NCT05949008
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 150 participants
- Registry
-
NCT05949008
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05949008. Randomized; double masking; primary purpose prevention. Start 2023-11-22 (actual); primary completion 2027-10-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
- Condition
- NIDDM
- Condition
- Obesity
- Intervention (Drug)
- Metformin Extended Release (ER) Oral Tablet
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of California, Los Angeles
Record details
- Record id
cardio:ct-nct05949008- Content hash
cebf4fc568000026d247241f912aa643f8e2823c1a8fb67a730924faf8d3eeb0